<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncol Lett</journal-id><journal-id journal-id-type="iso-abbrev">Oncol Lett</journal-id><journal-id journal-id-type="publisher-id">OL</journal-id><journal-title-group><journal-title>Oncology Letters</journal-title></journal-title-group><issn pub-type="ppub">1792-1074</issn><issn pub-type="epub">1792-1082</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6036478</article-id><article-id pub-id-type="doi">10.3892/ol.2018.8860</article-id><article-id pub-id-type="publisher-id">OL-0-0-8860</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Cross talk of chromosome instability, CpG island methylator phenotype and mismatch repair in colorectal cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Tian-Ming</given-names></name><xref ref-type="aff" rid="af1-ol-0-0-8860">1</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="af2-ol-0-0-8860">2</xref><xref rid="c2-ol-0-0-8860" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Rong-Fei</given-names></name><xref ref-type="aff" rid="af3-ol-0-0-8860">3</xref><xref rid="c1-ol-0-0-8860" ref-type="corresp"/></contrib></contrib-group><aff id="af1-ol-0-0-8860"><label>1</label>Department of Colorectal and Anal Surgery, Jinhua Hospital of Zhejiang University, Jinhua, Zhejiang 321000, P.R. China</aff><aff id="af2-ol-0-0-8860"><label>2</label>Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, P.R. China</aff><aff id="af3-ol-0-0-8860"><label>3</label>Department of Colorectal and Anal Surgery, Jinhua People's Hospital, Jinhua, Zhejiang 321000, P.R. China</aff><author-notes><corresp id="c1-ol-0-0-8860"><italic>Correspondence to</italic>: Dr Rong-Fei Wang, Department of Colorectal and Anal Surgery, Jinhua People's Hospital, 228 Xinhua Street, Jinhua, Zhejiang 321000, P.R. China, E-mail: <email>wrf961133@sina.com</email></corresp><corresp id="c2-ol-0-0-8860">Dr Tao Huang, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, P.R. China, E-mail: <email>tohuangtao@126.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>31</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>5</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>16</volume><issue>2</issue><fpage>1736</fpage><lpage>1746</lpage><history><date date-type="received"><day>12</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>22</day><month>5</month><year>2018</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Zhang et al.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><p>Colorectal cancer is a severe cancer associated with a high prevalence and fatality rate. There are three major mechanisms for colorectal cancer: (<xref rid="b1-ol-0-0-8860" ref-type="bibr">1</xref>) Chromosome instability (CIN), (<xref rid="b2-ol-0-0-8860" ref-type="bibr">2</xref>) CpG island methylator phenotype (CIMP) and (<xref rid="b3-ol-0-0-8860" ref-type="bibr">3</xref>) mismatch repair (MMR), of which CIN is the most common type. However, these subtypes are not exclusive and overlap. To investigate their biological mechanisms and cross talk, the gene expression profiles of 585 colorectal cancer patients with CIN, CIMP and MMR status records were collected. By comparing the CIN+ and CIN-samples, CIMP+ and CIMP-samples, MMR+ and MMR-samples with minimal redundancy maximal relevance (mRMR) and incremental feature selection (IFS) methods, the CIN, CIMP and MMR associated genes were selected. Unfortunately, there was little direct overlap among them. To investigate their indirect interactions, downstream genes of CIN, CIMP and MMR were identified using the random walk with restart (RWR) method and a greater overlap of downstream genes was indicated. The common downstream genes were involved in biosynthetic and metabolic pathways. These findings were consistent with the clinical observation of wide range metabolite aberrations in colorectal cancer. To conclude, the present study gave a gene level explanation of CIN, CIMP and MMR, but also showed the network level cross talk of CIN, CIMP and MMR. The common genes of CIN, CIMP and MMR may be useful for cross-subtype general colorectal cancer drug development.</p></abstract><kwd-group><kwd>chromosome instability</kwd><kwd>CpG island methylator phenotype</kwd><kwd>mismatch repair</kwd><kwd>minimal redundancy maximal relevance</kwd><kwd>incremental feature selection</kwd><kwd>random walk with restart</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Colorectal cancer is one of the most common cancer with leading cause of death (<xref rid="b1-ol-0-0-8860" ref-type="bibr">1</xref>). Its classical molecular events have been well-studied. The oncogenes in colorectal cancer are ras, scr and c-myc while the tumor suppressor genes are APC and p53. The Wnt pathway is considered to be important in the tumorgenesis of colorectal cancer. In 1990, Fearon and Vogelstein (<xref rid="b2-ol-0-0-8860" ref-type="bibr">2</xref>) proposed a famous model of colorectal cancer which believes a serials of gene and signaling pathway alterations contribute to the histology changes from normal tissue to adenoma and then to carcinoma. Li <italic>et al</italic> found that at each stage of colorectal cancer, their gene expression profiles were different (<xref rid="b3-ol-0-0-8860" ref-type="bibr">3</xref>). Jiang <italic>et al</italic> found that the early stage colorectal cancer biomarkers and late stage biomarkers were different and they can be connected by signal propagation on the network (<xref rid="b4-ol-0-0-8860" ref-type="bibr">4</xref>). Many genes were found to be associated with colorectal cancer by gene expression and network analysis (<xref rid="b5-ol-0-0-8860" ref-type="bibr">5</xref>,<xref rid="b6-ol-0-0-8860" ref-type="bibr">6</xref>). And many signaling pathways, such as Wnt/&#x003b2;-catenin signaling, epidermal growth factor receptor/Ras signaling, p53 signaling, Notch signaling, Hedgehog signaling, and Hippo signaling, were found to play roles in colorectal cancer (<xref rid="b7-ol-0-0-8860" ref-type="bibr">7</xref>).</p><p>To summary the current understandings of colorectal cancer, there are major mechanisms for colorectal cancer: (<xref rid="b1-ol-0-0-8860" ref-type="bibr">1</xref>) chromosome instability (CIN), (<xref rid="b2-ol-0-0-8860" ref-type="bibr">2</xref>) CpG island methylator phenotype (CIMP) and (<xref rid="b3-ol-0-0-8860" ref-type="bibr">3</xref>) mismatch repair (MMR). In approximately 85% of colorectal cancer patients, the chromosomal instability (CIN) is observed (<xref rid="b8-ol-0-0-8860" ref-type="bibr">8</xref>). They exhibited genomic instability on the chromosomal level. The CIN patients usually have the poorest prognosis (<xref rid="b9-ol-0-0-8860" ref-type="bibr">9</xref>). In approximately 15&#x02013;20% colorectal cancer patients, there are widespread CIMP (<xref rid="b10-ol-0-0-8860" ref-type="bibr">10</xref>). In approximately 15% colorectal cancer patients, Microsatellite instability (MSI) is detected (<xref rid="b11-ol-0-0-8860" ref-type="bibr">11</xref>). It is caused by the loss of DNA MMR activity. The MSI patients tend to have a good prognosis (<xref rid="b12-ol-0-0-8860" ref-type="bibr">12</xref>). These mechanisms are not mutually exclusive. For example, the MMR patients usually also show varying degrees of CIN (<xref rid="b8-ol-0-0-8860" ref-type="bibr">8</xref>). Different pathways that were used for characterizing each mechanism actually can interact with each other and cross talk (<xref rid="b7-ol-0-0-8860" ref-type="bibr">7</xref>). Multiple signaling pathways share transcription factors, microRNAs and ligases, such as miR-21, miR-145, FBXW7 and &#x003b2;-TrCP (<xref rid="b7-ol-0-0-8860" ref-type="bibr">7</xref>).</p><p>To systematically investigate the relationship between CIN, CIMP and MMR, we analyzed the gene expression profiles of 585 colorectal cancer patients. These patients were annotated with CIN, CIMP and MMR status. For each status, we applied advanced minimal redundancy maximal relevance (mRMR) and incremental feature selection (IFS) method to select its biomarkers genes. Then we overlapped the CIN, CIMP and MMR biomarker genes. Since they may not directly interact with each other, we used random walk with restart (RWR) method to find the region that the CIN, CIMP and MMR biomarker genes affect and investigated the commonly regulated genes by CIN, CIMP and MMR. The biological functions of these commonly regulated genes were analyzed. Our work found the molecular cross talk among CIN, CIMP and MMR, revealed the internal logic of colorectal tumorgenesis, and provided the emerging therapeutic targets that may be suitable for most colorectal cancer patients rather than a small proportion of patients.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title/><sec><title>The gene expression profiles of 585 colorectal cancer patients</title><p>We downloaded the gene expression profiles of 585 colorectal cancer patients from GEO (Gene Expression Omnibus) with accession number of GSE39582 (<xref rid="b13-ol-0-0-8860" ref-type="bibr">13</xref>). The expression levels were measured with Affymetrix Human Genome U133 Plus 2.0 Array which had 54,675 probes corresponding to 20,502 genes. The probes corresponding to the same gene were averaged. The gene expression data was preprocessed with quantile normalization. Within the 585 colon patients, there were 369 CIN+ and 112 CIN-, 93 CIMP+ and 420 CIMP-, 77 dMMR and 459 pMMR. For each analysis, the patients with missing status were excluded. For example, for CIN+ and CIN-comparison, the 369 CIN+ and 112 CIN-patients were considered while 104 without CIN information were excluded.</p></sec></sec><sec><title>The CIN-associated gene selection</title><sec><title>mRMR gene ranking</title><p>We used the mRMR method (<xref rid="b14-ol-0-0-8860" ref-type="bibr">14</xref>) to rank the genes based on their relevance with CIN status and their redundancy between genes. The mRMR method is based on information theory and has been widely used in bioinformatics filed (<xref rid="b15-ol-0-0-8860" ref-type="bibr">15</xref>&#x02013;<xref rid="b19-ol-0-0-8860" ref-type="bibr">19</xref>). To apply mRMR method, we used the C/C++ version mRMR software downloaded from <uri xlink:type="simple" xlink:href="http://home.penglab.com/proj/mRMR/">http://home.penglab.com/proj/mRMR/</uri>. With mRMR method, we obtained a ranked gene list. The top 500 mRMR genes were analyzed.</p></sec><sec><title>IFS</title><p>To determine how many genes should be selected from the mRMR gene list, we adopted the IFS method (<xref rid="b4-ol-0-0-8860" ref-type="bibr">4</xref>,<xref rid="b20-ol-0-0-8860" ref-type="bibr">20</xref>&#x02013;<xref rid="b24-ol-0-0-8860" ref-type="bibr">24</xref>) and constructed 500 support vector machine (SVM) classifiers. In this study, we used the svm function with default parameters from R package e10171 (<uri xlink:type="simple" xlink:href="https://cran.r-project.org/web/packages/e1071/">https://cran.r-project.org/web/packages/e1071/</uri>) to build the SVM classifier. Each time, the top k genes in the mRMR list was used to build the SVM classifier. And the performance of the top k-gene classifier was evaluated with leave-one-out cross validation (LOOCV). To objectively evaluate the classifier's performance, Sensitivity (Sn), Specificity (Sp), Accuracy (ACC) and Mathew's correlation coefficient (MCC) were calculated:</p><disp-formula><label>(1)</label><alternatives><mml:math id="umml1"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="ol-16-02-1736-g00.jpg" position="float" orientation="portrait"/></alternatives></disp-formula><disp-formula><label>(2)</label><alternatives><mml:math id="umml2"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>p</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="ol-16-02-1736-g01.jpg" position="float" orientation="portrait"/></alternatives></disp-formula><disp-formula><label>(3)</label><alternatives><mml:math id="umml3"><mml:mrow><mml:mi>A</mml:mi><mml:mi>C</mml:mi><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="ol-16-02-1736-g02.jpg" position="float" orientation="portrait"/></alternatives></disp-formula><disp-formula><label>(4)</label><alternatives><mml:math id="umml4"><mml:mrow><mml:mi>M</mml:mi><mml:mi>C</mml:mi><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:msqrt><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mspace width=".16em"/><mml:mo stretchy="false">(</mml:mo><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mspace width=".16em"/><mml:mo stretchy="false">(</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mspace width=".16em"/><mml:mo stretchy="false">(</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="ol-16-02-1736-g03.jpg" position="float" orientation="portrait"/></alternatives></disp-formula><p>where TP, TN, FP and FN stand for true positive (CIN+), true negative (CIN-), false positive (CIN+) and false negative (CIN-), respectively. Since the sizes of positive (CIN+) and negative (CIN-) samples were imbalance in this study, MCC which considered both Sn and Sp, was choose as the major measurement (<xref rid="b25-ol-0-0-8860" ref-type="bibr">25</xref>). At last, based on the IFS curve in which the number of top genes that were used as x-axis and the LOOCV MCCs of classifiers as y-axis, we can decide how many genes should be used to build a classifier with great performance and small complexity. The peak or the change point of the IFS curve were usually chosen.</p></sec><sec><title>The CIMP-associated gene selection</title><p>Similarly, we can identify the CIMP-associated genes using mRMR and IFS methods. Since the sample size of CIMP+ and CIMP-patients were also imbalance, the MCC was considered as the key measurement for prediction performance evaluation and was used to plot the IFS curve.</p></sec><sec><title>The MMR-associated gene selection</title><p>Similarly, we can identify the MMR-associated genes by analyzing the gene expression profiles pMMR and dMMR patients using mRMR and IFS methods. The dMMR and pMMR were considered as positive and negative samples, respectively. The MCC was used to plot the IFS curve since there were much more pMMR than dMMR.</p></sec><sec><title>The overlapped genes and common downstream genes of CIN, CIMP and MMR</title><p>We would like to known whether there is a general mechanism for CIN, CIMP and MMR. The direct way is to overlap the mRMR and IFS identified CIN associated genes, CIMP associated genes and MMR associated genes.</p><p>Since the identified CIN associated genes, CIMP associated genes and MMR associated genes may be incomplete or locate at the upstream of the colorectal cancer signaling pathway, we tried to pin down the area affected by the CIN associated genes, CIMP associated genes and MMR associated genes on the protein-protein interaction network of using RWR method (<xref rid="b26-ol-0-0-8860" ref-type="bibr">26</xref>&#x02013;<xref rid="b29-ol-0-0-8860" ref-type="bibr">29</xref>). The STRING network (version 10.0) (<xref rid="b30-ol-0-0-8860" ref-type="bibr">30</xref>) is a comprehensive protein-protein functional association network that has been widely used (<xref rid="b26-ol-0-0-8860" ref-type="bibr">26</xref>,<xref rid="b28-ol-0-0-8860" ref-type="bibr">28</xref>,<xref rid="b31-ol-0-0-8860" ref-type="bibr">31</xref>&#x02013;<xref rid="b39-ol-0-0-8860" ref-type="bibr">39</xref>). It included 19,247 proteins and 4,274,001 interactions. We constructed the network using the protein-protein interactions with confidence score &#x0003e;0.900 which is the highest confidence interaction in STRING database. Then the n*n adjacent matrix (<italic>A</italic>) of the network which included n proteins was column-wise normalized to make the column sum to be 1 by assign 1/m to the m interaction proteins of protein j in column j and 0 to other proteins without interactions.</p><p>The random walk procedure repeat in every time tick (t&#x02192;t+1) from the initial seed genes which were represented as a n length vector with <italic>P</italic><sub>0</sub> value of 1/k for the k seed genes and value of 0 for other n-k non-seed genes. The state probabilities <italic>P</italic><sub>t+1</sub> at time t+1 is calculated as follow: <italic>P</italic><sub>t+1=(1-r)</sub><italic><sub>AP</sub></italic><sub>t+r</sub><italic><sub>P</sub></italic><sub>0</sub> (<xref rid="b5-ol-0-0-8860" ref-type="bibr">5</xref>), where <italic>P</italic><sub>t</sub> is state probabilities at time t, r is the restart probability which is set to 0.7 as suggested by previous studies (<xref rid="b26-ol-0-0-8860" ref-type="bibr">26</xref>&#x02013;<xref rid="b29-ol-0-0-8860" ref-type="bibr">29</xref>,<xref rid="b40-ol-0-0-8860" ref-type="bibr">40</xref>). It has been reported that if r is in a sizable range (0.5&#x02013;0.8), the results will have little difference (<xref rid="b40-ol-0-0-8860" ref-type="bibr">40</xref>). These random walk process will stop when the difference between two steps is smaller than 1e-6. At last, all genes on the network will be assigned with a RWR score which corresponds to the probability of being expanded from the seed genes.</p><p>To statically evaluate the significance of RWR score, we randomly chosen the same number of seed genes and calculated their RWR scores for 1,000 times. The significance of actual RWR score can be defined as a permutation P-value of how times the random RWR scores was greater than the actual RWR score over the permutation times which was 1,000 in this study. The genes with permutation P-value smaller than 0.05 were considered as significant RWR expanded genes.</p><p>The RWR expanded genes can represent the downstream genes of CIN, CIMP and MMR and be used for common downstream gene analysis. The functions of the common CIN, CIMP and MMR downstream genes were enriched onto KEGG pathways and Gene Ontology (GO) terms using hypergeometric test.</p></sec></sec></sec><sec><title>Results and Discussion</title><sec><title/><sec><title>The CIN associated genes identified with mRMR and IFS</title><p>The top 500 most discriminative genes between CIN+ and CIN-samples were ranked using the mRMR method which considered both their relevance with CIN status, and their redundancy with selected genes. After the genes were ranked by mRMR, we chosen the number of top genes by applying the IFS procedure. Different number of top genes were tried and their prediction performance were evaluated. The IFS curve with the number of genes as x-axis and leave one out cross validation MCC as y-axis was shown in <xref rid="f1-ol-0-0-8860" ref-type="fig">Fig. 1A</xref>. It can be seen that when 34 genes were used, the leave one out cross validation MCC was the highest. The leave one out cross validation Sn, Sp, ACC and MCC of these 34 genes were 0.932, 0.696, 0.877 and 0.648, respectively. Therefore these 34 genes were chosen and shown in <xref rid="tI-ol-0-0-8860" ref-type="table">Table I</xref>. As shown in <xref rid="f2-ol-0-0-8860" ref-type="fig">Fig. 2A</xref>, the 34 CIN associated genes can cluster the CIN+ and CIN-patients into the right groups. IVD, NDUFAF1, OIP5-AS1, EXOSC9, HSPA4L, RPL22L1, EMC6, NCBP3, CYB5D1, PRPSAP2, RALBP1, ATP9B, ADGRG6, TRIM7, NLRX1, RNF145, CTC1, TMEM102 were highly expressed in CIN-patients while TGFBR2, HERPUD2, KBTBD2, ROCK2, TUFT1, TMEM176A, RHEB, SERINC3, STX16, COMMD7, DYNLRB1, RTFDC1, EIF6, TM9SF4, HEATR4, RRNAD1 were highly expressed in CIN+ patients.</p></sec><sec><title>The CIMP associated genes identified with mRMR and IFS</title><p>Similarly, the CIMP associated genes can be identified using mRMR and IFS methods. As a result, 19 genes were selected based on the IFS curve shown in <xref rid="f1-ol-0-0-8860" ref-type="fig">Fig. 1B</xref> and listed in <xref rid="tII-ol-0-0-8860" ref-type="table">Table II</xref>. The 19 genes' leave one out cross validation Sn, Sp, ACC and MCC were 0.710, 0.976, 0.928 and 0.744, respectively. As shown in <xref rid="f2-ol-0-0-8860" ref-type="fig">Fig. 2B</xref>, the 19 CIMP associated genes can cluster the CIMP+ and CIMP-patients into the right groups. VANGL2, ZNF665, JUN, FAM84A, ZBTB38, GRM8, DUSP18, PRDX5, HUNK, QPRT, ZNF141, MLH1, MTERF1 were highly expressed in CIMP-patients while PIWIL1, ADGRG6, FOXD1, HOXC6, AFAP1-AS1, HS3ST1 were highly expressed in CIMP+ patients.</p></sec><sec><title>The MMR associated genes identified with mRMR and IFS</title><p>Similarly, the MMR associated genes can be identified using mRMR and IFS methods. As a result, 18 genes were selected based on the IFS curve shown in <xref rid="f1-ol-0-0-8860" ref-type="fig">Fig. 1C</xref> and listed in <xref rid="tIII-ol-0-0-8860" ref-type="table">Table III</xref>. The leave one out cross validation Sn, Sp, ACC and MCC of these 18 genes were 0.922, 0.985, 0.976 and 0.902, respectively. As shown in <xref rid="f2-ol-0-0-8860" ref-type="fig">Fig. 2C</xref>, the 18 MMR associated genes can cluster the MMR+ and MMR-patients into the right groups. CAB39L, H2AFJ, TGFBR2, MLH1, SEC22B, BRD3, FBXO21, FOXO3, INO80D were highly expressed in MMR-patients while EIF5A, RAPGEF6, LYG1, HNRNPL, MTA2, HPSE, STRN3, MIR3916, RAB12 were highly expressed in MMR+ patients.</p></sec><sec><title>The direct overlap between CIN associated genes, CIMP associated genes and MMR associated genes</title><p>As three major mechanisms of colorectal cancer, we would like to investigate whether there were overlaps between CIN associated genes, CIMP associated genes and MMR associated genes. The Venn diagram of CIN associated genes, CIMP associated genes and MMR associated genes were shown in <xref rid="f3-ol-0-0-8860" ref-type="fig">Fig. 3</xref>. It can be seen that none genes were common in these three gene lists. The overlap between CIN and CIMP was ADGRG6, the common gene between CIN and MMR was TGFBR2 and the overlap between CIMP and MMR was MLH1. The references of ADGRG6 was limited and its functions were largely unknown. Interestingly, TGFBR2 has been reported as a candidate driver gene in MSI colorectal cancer (<xref rid="b41-ol-0-0-8860" ref-type="bibr">41</xref>) and the MMR patients usually also show varying degrees of CIN (<xref rid="b8-ol-0-0-8860" ref-type="bibr">8</xref>). TGFBR2 may be key of the association of CIN and MMR. The correlation of MLH1 methylation and MMR status has been reported (<xref rid="b42-ol-0-0-8860" ref-type="bibr">42</xref>) and it confirmed the association of CIMP and MMR.</p></sec><sec><title>The cross talk between CIN, CIMP and MMR</title><p>Since there is little overlap between the CIN associated genes, CIMP associated genes and MMR associated genes identified by mRMR and IFS, we would like to investigate whether they have common downstream genes. To verify this, we used the workflow shown in <xref rid="f4-ol-0-0-8860" ref-type="fig">Fig. 4</xref> to investigate the cross talk between CIN, CIMP and MMR. The key is step (C) which identifies the genes that the CIN, CIMP and MMR affects, i.e. the downstream genes of CIN, CIMP and MMR. To do so, first we mapped the CIN associated genes onto the network and then, expanded them using RWR network on the network. At last, by comparing with random permutations, the significant RWR expanded genes were identified as the downstream of CIN. Similarly, the downstream genes of CIMP and MMR can be identified.</p><p>The numbers of downstream genes of CIN, CIMP and MMR with permutation P-value &#x0003c;0.05 were 745, 709 and 807, respectively. <xref rid="f5-ol-0-0-8860" ref-type="fig">Fig. 5</xref> showed the overlap among CIN, CIMP and MMR and there were 236 common downstream genes of CIN, CIMP and MMR. These 236 genes were shown in <xref rid="tIV-ol-0-0-8860" ref-type="table">Table IV</xref>. To statistically evaluate the significance of overlap, we calculated the odds ratio and P-value using R package Super Exact Test (<xref rid="b43-ol-0-0-8860" ref-type="bibr">43</xref>). The results were shown in <xref rid="f6-ol-0-0-8860" ref-type="fig">Fig. 6</xref>. The odds ratio of overlap was 60.3 and the P-value was smaller than 1e-320.</p><p>The biological functions of the overlapped genes were investigated by enriching them onto KEGG and GO. The enrichment results were summarized in <xref rid="tV-ol-0-0-8860" ref-type="table">Table V</xref>. It can be seen that the significantly enriched KEGG pathways with FDR (false discovery rate) &#x0003c;0.05 were: hsa00770 Pantothenate and CoA biosynthesis, hsa00785 Lipoic acid metabolism and hsa04514 Cell adhesion molecules (CAMs). Similarly, the most significantly enriched GO terms were: GO:0015937 coenzyme A biosynthetic process, GO:0015936 coenzyme A metabolic process, GO:0033866 nucleoside bisphosphate biosynthetic process, GO:0034030_ribonucleoside bisphosphate biosynthetic process and GO:0034033 purine nucleoside bisphosphate biosynthetic process. These results indicated that the CIN, CIMP and MMR all affect biosynthetic and metabolic process and pathway to accelerate the tumorgenesis. In clinic, the metabolic syndrome was found to be able to increase the risk of colorectal cancer (<xref rid="b44-ol-0-0-8860" ref-type="bibr">44</xref>). And in colorectal cancer cell, there are aberration of various metabolites, such as nucleotides, amino acids, tricarboxylic acid, carbohydrates, and pentose-phosphate (<xref rid="b45-ol-0-0-8860" ref-type="bibr">45</xref>).</p><p>As a complex disease, the colorectal cancer can be caused by several different mechanisms. The three well-known one were CIN, CIMP and MMR. They were different but not exclusive. We investigated the genes that were associated with CIN, CIMP and MMR, separately using mRMR and IFS methods. Then by direct overlapping the CIN associated genes, CIMP associated genes and MMR associated genes, they share little common genes. Therefore, they were highly possible to interact with each other indirectly. To verify this idea, we identified the downstream genes that the CIN associated genes, CIMP associated genes and MMR associated genes may affect using RWR method. After the RWR analysis, the overlap between CIN, CIMP and MMR become significantly greater and the common downstream genes were involved in biosynthetic and metabolic process and pathway. These results can help explain the non-exclusiveness of CIN, CIMP and MMR and why they may co-occur from a protein-protein interaction network view. What's more, the common genes of CIN, CIMP and MMR can be possible targets of new broad-spectrum anti-cancer drugs that can treat more patients.</p></sec></sec></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec><title>Funding</title><p>The present study was supported by Health and Family Planning Commission of Zhejiang Province (grant no. 2013kYA212), National Natural Science Foundation of China (grant no. 31701151), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (grant no. 2016245).</p></sec><sec><title>Availability of data and materials</title><p>The gene expression profiles of 585 colorectal cancer patients were obtained from GEO (Gene Expression Omnibus) with accession number of GSE39582.</p></sec><sec><title>Authors' contributions</title><p>RFW and TH designed the experiment. TMZ and TH performed the experiment, analyzed the data and wrote the manuscript.</p></sec><sec><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec><title>Consent for publication</title><p>Not applicable.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><title>References</title><ref id="b1-ol-0-0-8860"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R</given-names></name><name><surname>Desantis</surname><given-names>C</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Colorectal cancer statistics, 2014</article-title><source>CA Cancer J Clin</source><volume>64</volume><fpage>104</fpage><lpage>117</lpage><year>2014</year><pub-id pub-id-type="doi">10.3322/caac.21220</pub-id><?supplied-pmid 24639052?><pub-id pub-id-type="pmid">24639052</pub-id></element-citation></ref><ref id="b2-ol-0-0-8860"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fearon</surname><given-names>ER</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name></person-group><article-title>A genetic model for colorectal tumorigenesis</article-title><source>Cell</source><volume>61</volume><fpage>759</fpage><lpage>767</lpage><year>1990</year><pub-id pub-id-type="doi">10.1016/0092-8674(90)90186-I</pub-id><?supplied-pmid 2188735?><pub-id pub-id-type="pmid">2188735</pub-id></element-citation></ref><ref id="b3-ol-0-0-8860"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BQ</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>GH</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>An ensemble prognostic model for colorectal cancer</article-title><source>PLoS One</source><volume>8</volume><fpage>e63494</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0063494</pub-id><?supplied-pmid 23658834?><pub-id pub-id-type="pmid">23658834</pub-id></element-citation></ref><ref id="b4-ol-0-0-8860"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>YF</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Chou</surname><given-names>KC</given-names></name></person-group><article-title>Signal propagation in protein interaction network during colorectal cancer progression</article-title><source>BioMed Research International</source><volume>2013</volume><fpage>287019</fpage><year>2013</year><pub-id pub-id-type="doi">10.1155/2013/287019</pub-id><?supplied-pmid 23586028?><pub-id pub-id-type="pmid">23586028</pub-id></element-citation></ref><ref id="b5-ol-0-0-8860"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BQ</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name><name><surname>Chou</surname><given-names>KC</given-names></name></person-group><article-title>Identification of colorectal cancer related genes with mRMR and shortest path in protein-protein interaction network</article-title><source>PLoS One</source><volume>7</volume><fpage>e33393</fpage><year>2012</year><pub-id pub-id-type="doi">10.1371/journal.pone.0033393</pub-id><?supplied-pmid 22496748?><pub-id pub-id-type="pmid">22496748</pub-id></element-citation></ref><ref id="b6-ol-0-0-8860"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>BQ</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>The integrative network of gene expression, microRNA, methylation and copy number variation in colon and rectal cancer</article-title><source>Curr Bioinform</source><volume>11</volume><fpage>59</fpage><lpage>65</lpage><year>2016</year><pub-id pub-id-type="doi">10.2174/1574893611666151119215823</pub-id></element-citation></ref><ref id="b7-ol-0-0-8860"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>WK</given-names></name><name><surname>Wang</surname><given-names>XJ</given-names></name><name><surname>Cheng</surname><given-names>AS</given-names></name><name><surname>Luo</surname><given-names>MX</given-names></name><name><surname>Ng</surname><given-names>SS</given-names></name><name><surname>To</surname><given-names>KF</given-names></name><name><surname>Chan</surname><given-names>FK</given-names></name><name><surname>Cho</surname><given-names>CH</given-names></name><name><surname>Sung</surname><given-names>JJ</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis</article-title><source>Crit Rev Oncol Hematol</source><volume>86</volume><fpage>251</fpage><lpage>277</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.critrevonc.2012.11.009</pub-id><?supplied-pmid 23287077?><pub-id pub-id-type="pmid">23287077</pub-id></element-citation></ref><ref id="b8-ol-0-0-8860"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trautmann</surname><given-names>K</given-names></name><name><surname>Terdiman</surname><given-names>JP</given-names></name><name><surname>French</surname><given-names>AJ</given-names></name><name><surname>Roydasgupta</surname><given-names>R</given-names></name><name><surname>Sein</surname><given-names>N</given-names></name><name><surname>Kakar</surname><given-names>S</given-names></name><name><surname>Fridlyand</surname><given-names>J</given-names></name><name><surname>Snijders</surname><given-names>AM</given-names></name><name><surname>Albertson</surname><given-names>DG</given-names></name><name><surname>Thibodeau</surname><given-names>SN</given-names></name><name><surname>Waldman</surname><given-names>FM</given-names></name></person-group><article-title>Chromosomal instability in microsatellite-unstable and stable colon cancer</article-title><source>Clin Cancer Res</source><volume>12</volume><fpage>6379</fpage><lpage>6385</lpage><year>2006</year><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-1248</pub-id><?supplied-pmid 17085649?><pub-id pub-id-type="pmid">17085649</pub-id></element-citation></ref><ref id="b9-ol-0-0-8860"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>A</given-names></name><name><surname>Houlston</surname><given-names>R</given-names></name><name><surname>Tomlinson</surname><given-names>I</given-names></name></person-group><article-title>Association between chromosomal instability and prognosis in colorectal cancer: A meta-analysis</article-title><source>Gut</source><volume>57</volume><fpage>941</fpage><lpage>950</lpage><year>2008</year><pub-id pub-id-type="doi">10.1136/gut.2007.135004</pub-id><?supplied-pmid 18364437?><pub-id pub-id-type="pmid">18364437</pub-id></element-citation></ref><ref id="b10-ol-0-0-8860"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vedeld</surname><given-names>HM</given-names></name><name><surname>Merok</surname><given-names>M</given-names></name><name><surname>Jeanmougin</surname><given-names>M</given-names></name><name><surname>Danielsen</surname><given-names>SA</given-names></name><name><surname>Honne</surname><given-names>H</given-names></name><name><surname>Presthus</surname><given-names>GK</given-names></name><name><surname>Svindland</surname><given-names>A</given-names></name><name><surname>Sjo</surname><given-names>OH</given-names></name><name><surname>Hektoen</surname><given-names>M</given-names></name><name><surname>Eknaes</surname><given-names>M</given-names></name><etal/></person-group><article-title>CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers</article-title><source>Int J Cancer</source><volume>141</volume><fpage>967</fpage><lpage>976</lpage><year>2017</year><pub-id pub-id-type="doi">10.1002/ijc.30796</pub-id><?supplied-pmid 28542846?><pub-id pub-id-type="pmid">28542846</pub-id></element-citation></ref><ref id="b11-ol-0-0-8860"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boland</surname><given-names>CR</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name></person-group><article-title>Microsatellite instability in colorectal cancer</article-title><source>Gastroenterology</source><volume>138</volume><fpage>2073</fpage><lpage>2087.e3</lpage><year>2010</year><pub-id pub-id-type="doi">10.1053/j.gastro.2009.12.064</pub-id><?supplied-pmid 20420947?><pub-id pub-id-type="pmid">20420947</pub-id></element-citation></ref><ref id="b12-ol-0-0-8860"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastadisegni</surname><given-names>C</given-names></name><name><surname>Colafranceschi</surname><given-names>M</given-names></name><name><surname>Ottini</surname><given-names>L</given-names></name><name><surname>Dogliotti</surname><given-names>E</given-names></name></person-group><article-title>Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data</article-title><source>Eur J Cancer</source><volume>46</volume><fpage>2788</fpage><lpage>2798</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.ejca.2010.05.009</pub-id><?supplied-pmid 20627535?><pub-id pub-id-type="pmid">20627535</pub-id></element-citation></ref><ref id="b13-ol-0-0-8860"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marisa</surname><given-names>L</given-names></name><name><surname>de Reyni&#x000e8;s</surname><given-names>A</given-names></name><name><surname>Duval</surname><given-names>A</given-names></name><name><surname>Selves</surname><given-names>J</given-names></name><name><surname>Gaub</surname><given-names>MP</given-names></name><name><surname>Vescovo</surname><given-names>L</given-names></name><name><surname>Etienne-Grimaldi</surname><given-names>MC</given-names></name><name><surname>Schiappa</surname><given-names>R</given-names></name><name><surname>Guenot</surname><given-names>D</given-names></name><name><surname>Ayadi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Gene expression classification of colon cancer into molecular subtypes: Characterization, validation, and prognostic value</article-title><source>PLoS Med</source><volume>10</volume><fpage>e1001453</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pmed.1001453</pub-id><?supplied-pmid 23700391?><pub-id pub-id-type="pmid">23700391</pub-id></element-citation></ref><ref id="b14-ol-0-0-8860"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Long</surname><given-names>F</given-names></name><name><surname>Ding</surname><given-names>C</given-names></name></person-group><article-title>Feature selection based on mutual information: Criteria of max-dependency, max-relevance, and min-redundancy</article-title><source>IEEE Trans Pattern Anal Mach Intell</source><volume>27</volume><fpage>1226</fpage><lpage>1238</lpage><year>2005</year><pub-id pub-id-type="doi">10.1109/TPAMI.2005.159</pub-id><?supplied-pmid 16119262?><pub-id pub-id-type="pmid">16119262</pub-id></element-citation></ref><ref id="b15-ol-0-0-8860"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>BQ</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name><name><surname>Kong</surname><given-names>XY</given-names></name></person-group><article-title>A method to distinguish between lysine acetylation and lysine ubiquitination with feature selection and analysis</article-title><source>J Biomol Struct Dyn</source><volume>33</volume><fpage>2479</fpage><lpage>2490</lpage><year>2015</year><pub-id pub-id-type="doi">10.1080/07391102.2014.1001793</pub-id><?supplied-pmid 25616595?><pub-id pub-id-type="pmid">25616595</pub-id></element-citation></ref><ref id="b16-ol-0-0-8860"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>TH</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>BQ</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>HP</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>A novel method of predicting protein disordered regions based on sequence features</article-title><source>Biomed Res Int</source><volume>2013</volume><fpage>414327</fpage><year>2013</year><pub-id pub-id-type="doi">10.1155/2013/414327</pub-id><?supplied-pmid 23710446?><pub-id pub-id-type="pmid">23710446</pub-id></element-citation></ref><ref id="b17-ol-0-0-8860"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name></person-group><article-title>Prediction of substrate-enzyme-product interaction based on molecular descriptors and physicochemical properties</article-title><source>Biomed Res Int</source><volume>2013</volume><fpage>674215</fpage><year>2013</year><pub-id pub-id-type="doi">10.1155/2013/674215</pub-id><?supplied-pmid 24455714?><pub-id pub-id-type="pmid">24455714</pub-id></element-citation></ref><ref id="b18-ol-0-0-8860"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name></person-group><article-title>Classification of cancers based on copy number variation landscapes</article-title><source>Biochim Biophys Acta</source><volume>1860</volume><fpage>2750</fpage><lpage>2755</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.bbagen.2016.06.003</pub-id><?supplied-pmid 27266344?><pub-id pub-id-type="pmid">27266344</pub-id></element-citation></ref><ref id="b19-ol-0-0-8860"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Analysis and prediction of drug-drug interaction by minimum redundancy maximum relevance and incremental feature selection</article-title><source>J Biomol Struct Dyn</source><volume>35</volume><fpage>312</fpage><lpage>329</lpage><year>2017</year><pub-id pub-id-type="doi">10.1080/07391102.2016.1138142</pub-id><?supplied-pmid 26750516?><pub-id pub-id-type="pmid">26750516</pub-id></element-citation></ref><ref id="b20-ol-0-0-8860"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Discriminating between deleterious and neutral non-frameshifting indels based on protein interaction networks and hybrid properties</article-title><source>Mol Genet Genomics</source><volume>290</volume><fpage>343</fpage><lpage>352</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s00438-014-0922-5</pub-id><?supplied-pmid 25248637?><pub-id pub-id-type="pmid">25248637</pub-id></element-citation></ref><ref id="b21-ol-0-0-8860"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Predicting A-to-I RNA editing by feature selection and random forest</article-title><source>PLoS One</source><volume>9</volume><fpage>e110607</fpage><year>2014</year><pub-id pub-id-type="doi">10.1371/journal.pone.0110607</pub-id><?supplied-pmid 25338210?><pub-id pub-id-type="pmid">25338210</pub-id></element-citation></ref><ref id="b22-ol-0-0-8860"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BQ</given-names></name><name><surname>You</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Classification of non-small cell lung cancer based on copy number alterations</article-title><source>PLoS One</source><volume>9</volume><fpage>e88300</fpage><year>2014</year><pub-id pub-id-type="doi">10.1371/journal.pone.0088300</pub-id><?supplied-pmid 24505469?><pub-id pub-id-type="pmid">24505469</pub-id></element-citation></ref><ref id="b23-ol-0-0-8860"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>PW</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Kong</surname><given-names>XY</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Classifying ten types of major cancers based on reverse phase protein array profiles</article-title><source>PLoS One</source><volume>10</volume><fpage>e0123147</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0123147</pub-id><?supplied-pmid 25822500?><pub-id pub-id-type="pmid">25822500</pub-id></element-citation></ref><ref id="b24-ol-0-0-8860"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Genetic differences among ethnic groups</article-title><source>BMC Genomics</source><volume>16</volume><fpage>1093</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12864-015-2328-0</pub-id><?supplied-pmid 26690364?><pub-id pub-id-type="pmid">26690364</pub-id></element-citation></ref><ref id="b25-ol-0-0-8860"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Analysis of the preferences for splice codes across tissues</article-title><source>Protein Cell</source><volume>6</volume><fpage>904</fpage><lpage>907</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s13238-015-0226-5</pub-id><?supplied-pmid 26507841?><pub-id pub-id-type="pmid">26507841</pub-id></element-citation></ref><ref id="b26-ol-0-0-8860"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Identifying novel protein phenotype annotations by hybridizing protein-protein interactions and protein sequence similarities</article-title><source>Mol Genet Genomics</source><volume>291</volume><fpage>913</fpage><lpage>934</lpage><year>2016</year><pub-id pub-id-type="doi">10.1007/s00438-015-1157-9</pub-id><?supplied-pmid 26728152?><pub-id pub-id-type="pmid">26728152</pub-id></element-citation></ref><ref id="b27-ol-0-0-8860"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>A computational method using the random walk with restart algorithm for identifying novel epigenetic factors</article-title><source>Mol Genet Genomics</source><volume>293</volume><fpage>293</fpage><lpage>301</lpage><year>2018</year><pub-id pub-id-type="doi">10.1007/s00438-017-1374-5</pub-id><?supplied-pmid 28932904?><pub-id pub-id-type="pmid">28932904</pub-id></element-citation></ref><ref id="b28-ol-0-0-8860"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>An</surname><given-names>L</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name></person-group><article-title>A network-based method using a random walk with restart algorithm and screening tests to identify novel genes associated with Meni&#x000e8;re's disease</article-title><source>PLoS One</source><volume>12</volume><fpage>e0182592</fpage><year>2017</year><pub-id pub-id-type="doi">10.1371/journal.pone.0182592</pub-id><?supplied-pmid 28787010?><pub-id pub-id-type="pmid">28787010</pub-id></element-citation></ref><ref id="b29-ol-0-0-8860"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chu</surname><given-names>C</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>A hybrid computational method for the discovery of novel reproduction-related genes</article-title><source>PLoS One</source><volume>10</volume><fpage>e0117090</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0117090</pub-id><?supplied-pmid 25768094?><pub-id pub-id-type="pmid">25768094</pub-id></element-citation></ref><ref id="b30-ol-0-0-8860"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Franceschini</surname><given-names>A</given-names></name><name><surname>Wyder</surname><given-names>S</given-names></name><name><surname>Forslund</surname><given-names>K</given-names></name><name><surname>Heller</surname><given-names>D</given-names></name><name><surname>Huerta-Cepas</surname><given-names>J</given-names></name><name><surname>Simonovic</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>A</given-names></name><name><surname>Santos</surname><given-names>A</given-names></name><name><surname>Tsafou</surname><given-names>KP</given-names></name><etal/></person-group><article-title>STRING v10: Protein-protein interaction networks, integrated over the tree of life</article-title><source>Nucleic Acids Res</source><volume>43</volume><comment>(Database Issue):</comment><fpage>D447</fpage><lpage>D452</lpage><year>2015</year><pub-id pub-id-type="doi">10.1093/nar/gku1003</pub-id><?supplied-pmid 25352553?><pub-id pub-id-type="pmid">25352553</pub-id></element-citation></ref><ref id="b31-ol-0-0-8860"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Deciphering the relationship between obesity and various diseases from a network perspective</article-title><source>Genes (Basel)</source><volume>8</volume><issue>pii</issue><fpage>E392</fpage><year>2017</year><pub-id pub-id-type="doi">10.3390/genes8120392</pub-id><?supplied-pmid 29258237?><pub-id pub-id-type="pmid">29258237</pub-id></element-citation></ref><ref id="b32-ol-0-0-8860"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>Feng</surname><given-names>K</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Network-based method for identifying co-regeneration genes in bone, dentin, nerve and vessel tissues</article-title><source>Genes (Basel)</source><volume>8</volume><issue>pii</issue><fpage>E252</fpage><year>2017</year><pub-id pub-id-type="doi">10.3390/8100252</pub-id><?supplied-pmid 28974058?><pub-id pub-id-type="pmid">28974058</pub-id></element-citation></ref><ref id="b33-ol-0-0-8860"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name></person-group><article-title>Identification of novel proliferative diabetic retinopathy related genes on protein-protein interaction network</article-title><source>Neurocomputing</source><volume>217</volume><fpage>63</fpage><lpage>72</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.neucom.2015.09.136</pub-id></element-citation></ref><ref id="b34-ol-0-0-8860"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>WM</given-names></name><name><surname>Petralia</surname><given-names>F</given-names></name><name><surname>Mobbs</surname><given-names>CV</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Tu</surname><given-names>Z</given-names></name></person-group><article-title>Discover the network mechanisms underlying the connections between aging and age-related diseases</article-title><source>Sci Rep</source><volume>6</volume><fpage>32566</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/srep32566</pub-id><?supplied-pmid 27582315?><pub-id pub-id-type="pmid">27582315</pub-id></element-citation></ref><ref id="b35-ol-0-0-8860"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Mining for novel tumor suppressor genes using a shortest path approach</article-title><source>J Biomol Struct Dyn</source><volume>34</volume><fpage>664</fpage><lpage>675</lpage><year>2016</year><pub-id pub-id-type="doi">10.1080/07391102.2015.1042915</pub-id><?supplied-pmid 26209080?><pub-id pub-id-type="pmid">26209080</pub-id></element-citation></ref><ref id="b36-ol-0-0-8860"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>YH</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>M</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>Identification of novel candidate drivers connecting different dysfunctional levels for lung adenocarcinoma using protein-protein interactions and a shortest path approach</article-title><source>Sci Rep</source><volume>6</volume><fpage>29849</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/srep29849</pub-id><?supplied-pmid 27412431?><pub-id pub-id-type="pmid">27412431</pub-id></element-citation></ref><ref id="b37-ol-0-0-8860"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Prediction of enzyme's family based on protein-protein interaction network</article-title><source>Current Bioinform</source><volume>10</volume><fpage>16</fpage><lpage>21</lpage><year>2015</year><pub-id pub-id-type="doi">10.2174/157489361001150309122016</pub-id></element-citation></ref><ref id="b38-ol-0-0-8860"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chu</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>YD</given-names></name></person-group><article-title>A computational method for the identification of new candidate carcinogenic and non-carcinogenic chemicals</article-title><source>Mol Biosyst</source><volume>11</volume><fpage>2541</fpage><lpage>2550</lpage><year>2015</year><pub-id pub-id-type="doi">10.1039/C5MB00276A</pub-id><?supplied-pmid 26194467?><pub-id pub-id-type="pmid">26194467</pub-id></element-citation></ref><ref id="b39-ol-0-0-8860"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>CL</given-names></name><name><surname>Li</surname><given-names>LL</given-names></name><name><surname>Cai</surname><given-names>MH</given-names></name><name><surname>Chen</surname><given-names>WZ</given-names></name><name><surname>Xu</surname><given-names>YF</given-names></name><name><surname>O'Reilly</surname><given-names>PF</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>L</given-names></name></person-group><article-title>A new method for identifying causal genes of schizophrenia and anti-tuberculosis drug-induced hepatotoxicity</article-title><source>Sci Rep</source><volume>6</volume><fpage>32571</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/srep32571</pub-id><?supplied-pmid 27580934?><pub-id pub-id-type="pmid">27580934</pub-id></element-citation></ref><ref id="b40-ol-0-0-8860"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofree</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>JP</given-names></name><name><surname>Carter</surname><given-names>H</given-names></name><name><surname>Gross</surname><given-names>A</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><article-title>Network-based stratification of tumor mutations</article-title><source>Nat Methods</source><volume>10</volume><fpage>1108</fpage><lpage>1115</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/nmeth.2651</pub-id><?supplied-pmid 24037242?><pub-id pub-id-type="pmid">24037242</pub-id></element-citation></ref><ref id="b41-ol-0-0-8860"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alhopuro</surname><given-names>P</given-names></name><name><surname>Sammalkorpi</surname><given-names>H</given-names></name><name><surname>Niittym&#x000e4;ki</surname><given-names>I</given-names></name><name><surname>Bistr&#x000f6;m</surname><given-names>M</given-names></name><name><surname>Raitila</surname><given-names>A</given-names></name><name><surname>Saharinen</surname><given-names>J</given-names></name><name><surname>Nousiainen</surname><given-names>K</given-names></name><name><surname>Lehtonen</surname><given-names>HJ</given-names></name><name><surname>Heli&#x000f6;vaara</surname><given-names>E</given-names></name><name><surname>Puhakka</surname><given-names>J</given-names></name><etal/></person-group><article-title>Candidate driver genes in microsatellite-unstable colorectal cancer</article-title><source>Int J Cancer</source><volume>130</volume><fpage>1558</fpage><lpage>1566</lpage><year>2012</year><pub-id pub-id-type="doi">10.1002/ijc.26167</pub-id><?supplied-pmid 21544814?><pub-id pub-id-type="pmid">21544814</pub-id></element-citation></ref><ref id="b42-ol-0-0-8860"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>MT</given-names></name><name><surname>Buchanan</surname><given-names>DD</given-names></name><name><surname>Thompson</surname><given-names>B</given-names></name><name><surname>Young</surname><given-names>JP</given-names></name><name><surname>Spurdle</surname><given-names>AB</given-names></name></person-group><article-title>Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: A literature review assessing utility of tumour features for MMR variant classification</article-title><source>J Med Genet</source><volume>49</volume><fpage>151</fpage><lpage>157</lpage><year>2012</year><pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100714</pub-id><?supplied-pmid 22368298?><pub-id pub-id-type="pmid">22368298</pub-id></element-citation></ref><ref id="b43-ol-0-0-8860"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name></person-group><article-title>Efficient test and visualization of multi-set intersections</article-title><source>Sci Rep</source><volume>5</volume><fpage>16923</fpage><year>2015</year><pub-id pub-id-type="doi">10.1038/srep16923</pub-id><?supplied-pmid 26603754?><pub-id pub-id-type="pmid">26603754</pub-id></element-citation></ref><ref id="b44-ol-0-0-8860"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forootan</surname><given-names>M</given-names></name><name><surname>Tabatabaeefar</surname><given-names>M</given-names></name><name><surname>Yahyaei</surname><given-names>M</given-names></name><name><surname>Maghsoodi</surname><given-names>N</given-names></name></person-group><article-title>Metabolic syndrome and colorectal cancer: A cross-sectional survey</article-title><source>Asian Pac J Cancer Prev</source><volume>13</volume><fpage>4999</fpage><lpage>5002</lpage><year>2012</year><pub-id pub-id-type="doi">10.7314/APJCP.2012.13.10.4999</pub-id><?supplied-pmid 23244098?><pub-id pub-id-type="pmid">23244098</pub-id></element-citation></ref><ref id="b45-ol-0-0-8860"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DG</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Weir</surname><given-names>TL</given-names></name><name><surname>O'Malia</surname><given-names>J</given-names></name><name><surname>Bazan</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>RJ</given-names></name><name><surname>Ryan</surname><given-names>EP</given-names></name></person-group><article-title>Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool</article-title><source>Cancer Metab</source><volume>4</volume><fpage>11</fpage><year>2016</year><pub-id pub-id-type="doi">10.1186/s40170-016-0151-y</pub-id><?supplied-pmid 27275383?><pub-id pub-id-type="pmid">27275383</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ol-0-0-8860" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>The IFS curves of CIN, CIMP and MMR. (A) The IFS curve of CIN. The top 34 mRMR genes were chosen and their LOOCV sensitivity, specificity, accuracy and MCC were 0.932, 0.696, 0.877 and 0.648, respectively. (B) The IFS curve of CIMP. The top 19 mRMR genes were chosen and their leave one out cross validation sensitivity, specificity, accuracy and MCC were 0.710, 0.976, 0.928 and 0.744, respectively. (C) The IFS curve of MMR. The top 18 mRMR genes were chosen and their leave one out cross validation sensitivity, specificity, accuracy and MCC were 0.922, 0.985, 0.976 and 0.902, respectively. IFS, incremental feature selection; CIN, chromosome instability; CIMP, CpG island methylator phenotype; MMR, mismatch repair; mRMR, minimal redundancy maximal relevance; LOOCV, leave-one-out cross validation.</p></caption><graphic xlink:href="ol-16-02-1736-g04"/></fig><fig id="f2-ol-0-0-8860" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>The heatmaps of CIN, CIMP and MMR. (A) The heatmap of CIN. The 34 CIN associated genes were used to cluster the CIN+ and CIN-patients. (B) The heatmap of CIMP. The 19 CIMP associated genes were used to cluster the CIMP+ and CIMP- patients. (C) The heatmap of MMR. The 18 MMR associated genes were used to cluster the MMR+ and MMR- patients. CIN, chromosome instability; CIMP, CpG island methylator phenotype; MMR, mismatch repair.</p></caption><graphic xlink:href="ol-16-02-1736-g05"/></fig><fig id="f3-ol-0-0-8860" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>The Venn diagram of CIN associated genes, CIMP associated genes and MMR associated genes. None genes were common in these three gene lists. The overlap between CIN and CIMP was ADGRG6, the common gene between CIN and MMR was TGFBR2 and the overlap between CIMP and MMR was MLH1. CIN, chromosome instability; CIMP, CpG island methylator phenotype; MMR, mismatch repair.</p></caption><graphic xlink:href="ol-16-02-1736-g06"/></fig><fig id="f4-ol-0-0-8860" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>The workflow to investigate the cross talk among CIN, CIMP and MMR. (A) The CIN associated genes, CIMP associated genes and MMR associated genes were identified using mRMR and IFS methods. (B) The direct overlap between CIN genes, CIMP genes and MMR genes were little. (C) The genes that the CIN genes, CIMP genes and MMR genes affect were identified using RWR method. (D) When both the CIN genes, CIMP genes and MMR genes and their RWR genes were considered, the overlap among CIN, CIMP and MMR was significantly increased. (E) The biological functions of the common genes (the red star) were studied. CIN, chromosome instability; CIMP, CpG island methylator phenotype; MMR, mismatch repair; mRMR, minimal redundancy maximal relevance; IFS, incremental feature selection; RWR, random walk with restart.</p></caption><graphic xlink:href="ol-16-02-1736-g07"/></fig><fig id="f5-ol-0-0-8860" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>The Venn diagram of CIN downstream genes, CIMP downstream genes and MMR downstream genes. There were 236 common downstream genes of CIN, CIMP and MMR. CIN, chromosome instability; CIMP, CpG island methylator phenotype; MMR, mismatch repair; RWR, random walk with restart.</p></caption><graphic xlink:href="ol-16-02-1736-g08"/></fig><fig id="f6-ol-0-0-8860" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>The significance of overlap among CIN downstream genes, CIMP downstream genes and MMR downstream genes. To statistically evaluate the significance of overlap, we calculated the odds ratio and p value using R package Super Exact Test. The odds ratio of overlap was 60.3 and the P-value was smaller than 1e-320. CIN, chromosome instability; CIMP, CpG island methylator phenotype; MMR, mismatch repair.</p></caption><graphic xlink:href="ol-16-02-1736-g09"/></fig><table-wrap id="tI-ol-0-0-8860" orientation="portrait" position="float"><label>Table I.</label><caption><p>The 34 chromosome instability-associated genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Order</th><th align="center" valign="bottom" rowspan="1" colspan="1">Symbol</th><th align="center" valign="bottom" rowspan="1" colspan="1">Name</th><th align="center" valign="bottom" rowspan="1" colspan="1">Entrez gene</th><th align="center" valign="bottom" rowspan="1" colspan="1">mRMR score</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;1</td><td align="left" valign="top" rowspan="1" colspan="1">STX16</td><td align="left" valign="top" rowspan="1" colspan="1">Syntaxin 16</td><td align="right" valign="top" rowspan="1" colspan="1">8675</td><td align="center" valign="top" rowspan="1" colspan="1">0.161</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;2</td><td align="left" valign="top" rowspan="1" colspan="1">NCBP3</td><td align="left" valign="top" rowspan="1" colspan="1">Nuclear cap binding subunit 3</td><td align="right" valign="top" rowspan="1" colspan="1">55421</td><td align="center" valign="top" rowspan="1" colspan="1">0.062</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;3</td><td align="left" valign="top" rowspan="1" colspan="1">IVD</td><td align="left" valign="top" rowspan="1" colspan="1">Isovaleryl-CoA dehydrogenase</td><td align="right" valign="top" rowspan="1" colspan="1">3712</td><td align="center" valign="top" rowspan="1" colspan="1">0.061</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;4</td><td align="left" valign="top" rowspan="1" colspan="1">DYNLRB1</td><td align="left" valign="top" rowspan="1" colspan="1">Dynein light chain roadblock-type 1</td><td align="right" valign="top" rowspan="1" colspan="1">83658</td><td align="center" valign="top" rowspan="1" colspan="1">0.067</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;5</td><td align="left" valign="top" rowspan="1" colspan="1">EXOSC9</td><td align="left" valign="top" rowspan="1" colspan="1">Exosome component 9</td><td align="right" valign="top" rowspan="1" colspan="1">5393</td><td align="center" valign="top" rowspan="1" colspan="1">0.044</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;6</td><td align="left" valign="top" rowspan="1" colspan="1">ATP9B</td><td align="left" valign="top" rowspan="1" colspan="1">ATPase phospholipid transporting 9B (putative)</td><td align="right" valign="top" rowspan="1" colspan="1">374868</td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;7</td><td align="left" valign="top" rowspan="1" colspan="1">KBTBD2</td><td align="left" valign="top" rowspan="1" colspan="1">Kelch repeat and BTB domain containing 2</td><td align="right" valign="top" rowspan="1" colspan="1">25948</td><td align="center" valign="top" rowspan="1" colspan="1">0.042</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;8</td><td align="left" valign="top" rowspan="1" colspan="1">EMC6</td><td align="left" valign="top" rowspan="1" colspan="1">ER membrane protein complex subunit 6</td><td align="right" valign="top" rowspan="1" colspan="1">83460</td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;9</td><td align="left" valign="top" rowspan="1" colspan="1">ADGRG6</td><td align="left" valign="top" rowspan="1" colspan="1">Adhesion G protein-coupled receptor G6</td><td align="right" valign="top" rowspan="1" colspan="1">57211</td><td align="center" valign="top" rowspan="1" colspan="1">0.046</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">OIP5-AS1</td><td align="left" valign="top" rowspan="1" colspan="1">OIP5 antisense RNA 1</td><td align="right" valign="top" rowspan="1" colspan="1">729082</td><td align="center" valign="top" rowspan="1" colspan="1">0.044</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">RNF145</td><td align="left" valign="top" rowspan="1" colspan="1">Ring finger protein 145</td><td align="right" valign="top" rowspan="1" colspan="1">153830</td><td align="center" valign="top" rowspan="1" colspan="1">0.043</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">COMMD7</td><td align="left" valign="top" rowspan="1" colspan="1">COMM domain containing 7</td><td align="right" valign="top" rowspan="1" colspan="1">149951</td><td align="center" valign="top" rowspan="1" colspan="1">0.046</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">TUFT1</td><td align="left" valign="top" rowspan="1" colspan="1">Tuftelin 1</td><td align="right" valign="top" rowspan="1" colspan="1">7286</td><td align="center" valign="top" rowspan="1" colspan="1">0.038</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">NLRX1</td><td align="left" valign="top" rowspan="1" colspan="1">NLR family member X1</td><td align="right" valign="top" rowspan="1" colspan="1">79671</td><td align="center" valign="top" rowspan="1" colspan="1">0.036</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">CYB5D1</td><td align="left" valign="top" rowspan="1" colspan="1">Cytochrome b5 domain containing 1</td><td align="right" valign="top" rowspan="1" colspan="1">124637</td><td align="center" valign="top" rowspan="1" colspan="1">0.038</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">RTFDC1</td><td align="left" valign="top" rowspan="1" colspan="1">Replication termination factor 2 domain containing 1</td><td align="right" valign="top" rowspan="1" colspan="1">51507</td><td align="center" valign="top" rowspan="1" colspan="1">0.037</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">RPL22L1</td><td align="left" valign="top" rowspan="1" colspan="1">Ribosomal protein L22 like 1</td><td align="right" valign="top" rowspan="1" colspan="1">200916</td><td align="center" valign="top" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">TMEM102</td><td align="left" valign="top" rowspan="1" colspan="1">Transmembrane protein 102</td><td align="right" valign="top" rowspan="1" colspan="1">284114</td><td align="center" valign="top" rowspan="1" colspan="1">0.032</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1">TM9SF4</td><td align="left" valign="top" rowspan="1" colspan="1">Transmembrane 9 superfamily member 4</td><td align="right" valign="top" rowspan="1" colspan="1">9777</td><td align="center" valign="top" rowspan="1" colspan="1">0.035</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">HERPUD2</td><td align="left" valign="top" rowspan="1" colspan="1">HERPUD family member 2</td><td align="right" valign="top" rowspan="1" colspan="1">64224</td><td align="center" valign="top" rowspan="1" colspan="1">0.033</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">RHEB</td><td align="left" valign="top" rowspan="1" colspan="1">Ras homolog enriched in brain</td><td align="right" valign="top" rowspan="1" colspan="1">6009</td><td align="center" valign="top" rowspan="1" colspan="1">0.033</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="left" valign="top" rowspan="1" colspan="1">NDUFAF1</td><td align="left" valign="top" rowspan="1" colspan="1">NADH:ubiquinone oxidoreductase complex assembly factor 1</td><td align="right" valign="top" rowspan="1" colspan="1">51103</td><td align="center" valign="top" rowspan="1" colspan="1">0.033</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">TGFBR2</td><td align="left" valign="top" rowspan="1" colspan="1">Transforming growth factor &#x003b2; receptor 2</td><td align="right" valign="top" rowspan="1" colspan="1">7048</td><td align="center" valign="top" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="left" valign="top" rowspan="1" colspan="1">TRIM7</td><td align="left" valign="top" rowspan="1" colspan="1">Tripartite motif containing 7</td><td align="right" valign="top" rowspan="1" colspan="1">81786</td><td align="center" valign="top" rowspan="1" colspan="1">0.032</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">PRPSAP2</td><td align="left" valign="top" rowspan="1" colspan="1">Phosphoribosyl pyrophosphate synthetase associated protein 2</td><td align="right" valign="top" rowspan="1" colspan="1">5636</td><td align="center" valign="top" rowspan="1" colspan="1">0.032</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">HEATR4</td><td align="left" valign="top" rowspan="1" colspan="1">HEAT repeat containing 4</td><td align="right" valign="top" rowspan="1" colspan="1">399671</td><td align="center" valign="top" rowspan="1" colspan="1">0.032</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">27</td><td align="left" valign="top" rowspan="1" colspan="1">SERINC3</td><td align="left" valign="top" rowspan="1" colspan="1">Serine incorporator 3</td><td align="right" valign="top" rowspan="1" colspan="1">10955</td><td align="center" valign="top" rowspan="1" colspan="1">0.034</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">28</td><td align="left" valign="top" rowspan="1" colspan="1">HSPA4L</td><td align="left" valign="top" rowspan="1" colspan="1">Heat shock protein family A (Hsp70) member 4 like</td><td align="right" valign="top" rowspan="1" colspan="1">22824</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">29</td><td align="left" valign="top" rowspan="1" colspan="1">RALBP1</td><td align="left" valign="top" rowspan="1" colspan="1">RalA binding protein 1</td><td align="right" valign="top" rowspan="1" colspan="1">10928</td><td align="center" valign="top" rowspan="1" colspan="1">0.029</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">RRNAD1</td><td align="left" valign="top" rowspan="1" colspan="1">Ribosomal RNA adenine dimethylase domain containing 1</td><td align="right" valign="top" rowspan="1" colspan="1">51093</td><td align="center" valign="top" rowspan="1" colspan="1">0.029</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="left" valign="top" rowspan="1" colspan="1">CTC1</td><td align="left" valign="top" rowspan="1" colspan="1">CST telomere replication complex component 1</td><td align="right" valign="top" rowspan="1" colspan="1">80169</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">32</td><td align="left" valign="top" rowspan="1" colspan="1">EIF6</td><td align="left" valign="top" rowspan="1" colspan="1">Eukaryotic translation initiation factor 6</td><td align="right" valign="top" rowspan="1" colspan="1">3692</td><td align="center" valign="top" rowspan="1" colspan="1">0.031</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">33</td><td align="left" valign="top" rowspan="1" colspan="1">TMEM176A</td><td align="left" valign="top" rowspan="1" colspan="1">Transmembrane protein 176A</td><td align="right" valign="top" rowspan="1" colspan="1">55365</td><td align="center" valign="top" rowspan="1" colspan="1">0.031</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="left" valign="top" rowspan="1" colspan="1">ROCK2</td><td align="left" valign="top" rowspan="1" colspan="1">Rho associated coiled-coil containing protein kinase 2</td><td align="right" valign="top" rowspan="1" colspan="1">9475</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td></tr></tbody></table></table-wrap><table-wrap id="tII-ol-0-0-8860" orientation="portrait" position="float"><label>Table II.</label><caption><p>The 19 CpG island methylator phenotype-associated genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Order</th><th align="center" valign="bottom" rowspan="1" colspan="1">Name</th><th align="center" valign="bottom" rowspan="1" colspan="1">Gene name</th><th align="center" valign="bottom" rowspan="1" colspan="1">Entrez gene</th><th align="center" valign="bottom" rowspan="1" colspan="1">mRMR score</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">MLH1</td><td align="left" valign="top" rowspan="1" colspan="1">mutL homolog 1</td><td align="right" valign="top" rowspan="1" colspan="1">4292</td><td align="center" valign="top" rowspan="1" colspan="1">0.193</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">HUNK</td><td align="left" valign="top" rowspan="1" colspan="1">Hormonally up-regulated Neu-associated kinase</td><td align="right" valign="top" rowspan="1" colspan="1">30811</td><td align="center" valign="top" rowspan="1" colspan="1">0.069</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">ZNF141</td><td align="left" valign="top" rowspan="1" colspan="1">Zinc finger protein 141</td><td align="right" valign="top" rowspan="1" colspan="1">7700</td><td align="center" valign="top" rowspan="1" colspan="1">0.063</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">DUSP18</td><td align="left" valign="top" rowspan="1" colspan="1">Dual specificity phosphatase 18</td><td align="right" valign="top" rowspan="1" colspan="1">150290</td><td align="center" valign="top" rowspan="1" colspan="1">0.058</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">ADGRG6</td><td align="left" valign="top" rowspan="1" colspan="1">Adhesion G protein-coupled receptor G6</td><td align="right" valign="top" rowspan="1" colspan="1">57211</td><td align="center" valign="top" rowspan="1" colspan="1">0.053</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">FOXD1</td><td align="left" valign="top" rowspan="1" colspan="1">Forkhead box D1</td><td align="right" valign="top" rowspan="1" colspan="1">2297</td><td align="center" valign="top" rowspan="1" colspan="1">0.052</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">FAM84A</td><td align="left" valign="top" rowspan="1" colspan="1">Family with sequence similarity 84 member A</td><td align="right" valign="top" rowspan="1" colspan="1">151354</td><td align="center" valign="top" rowspan="1" colspan="1">0.049</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">AFAP1-AS1</td><td align="left" valign="top" rowspan="1" colspan="1">AFAP1 antisense RNA 1</td><td align="right" valign="top" rowspan="1" colspan="1">84740</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">ZBTB38</td><td align="left" valign="top" rowspan="1" colspan="1">Zinc finger and BTB domain containing 38</td><td align="right" valign="top" rowspan="1" colspan="1">253461</td><td align="center" valign="top" rowspan="1" colspan="1">0.052</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">VANGL2</td><td align="left" valign="top" rowspan="1" colspan="1">VANGL planar cell polarity protein 2</td><td align="right" valign="top" rowspan="1" colspan="1">57216</td><td align="center" valign="top" rowspan="1" colspan="1">0.054</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">PRDX5</td><td align="left" valign="top" rowspan="1" colspan="1">Peroxiredoxin 5</td><td align="right" valign="top" rowspan="1" colspan="1">25824</td><td align="center" valign="top" rowspan="1" colspan="1">0.049</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">MTERF1</td><td align="left" valign="top" rowspan="1" colspan="1">Mitochondrial transcription termination factor 1</td><td align="right" valign="top" rowspan="1" colspan="1">7978</td><td align="center" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">QPRT</td><td align="left" valign="top" rowspan="1" colspan="1">Quinolinate phosphoribosyltransferase</td><td align="right" valign="top" rowspan="1" colspan="1">23475</td><td align="center" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">HOXC6</td><td align="left" valign="top" rowspan="1" colspan="1">Homeobox C6</td><td align="right" valign="top" rowspan="1" colspan="1">3223</td><td align="center" valign="top" rowspan="1" colspan="1">0.045</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">HS3ST1</td><td align="left" valign="top" rowspan="1" colspan="1">Heparan sulfate-glucosamine 3-sulfotransferase 1</td><td align="right" valign="top" rowspan="1" colspan="1">9957</td><td align="center" valign="top" rowspan="1" colspan="1">0.044</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">PIWIL1</td><td align="left" valign="top" rowspan="1" colspan="1">Piwi like RNA-mediated gene silencing 1</td><td align="right" valign="top" rowspan="1" colspan="1">9271</td><td align="center" valign="top" rowspan="1" colspan="1">0.046</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">JUN</td><td align="left" valign="top" rowspan="1" colspan="1">Jun proto-oncogene, AP-1 transcription factor subunit</td><td align="right" valign="top" rowspan="1" colspan="1">3725</td><td align="center" valign="top" rowspan="1" colspan="1">0.047</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">GRM8</td><td align="left" valign="top" rowspan="1" colspan="1">Glutamate metabotropic receptor 8</td><td align="right" valign="top" rowspan="1" colspan="1">2918</td><td align="center" valign="top" rowspan="1" colspan="1">0.045</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1">ZNF665</td><td align="left" valign="top" rowspan="1" colspan="1">Zinc finger protein 665</td><td align="right" valign="top" rowspan="1" colspan="1">79788</td><td align="center" valign="top" rowspan="1" colspan="1">0.046</td></tr></tbody></table></table-wrap><table-wrap id="tIII-ol-0-0-8860" orientation="portrait" position="float"><label>Table III.</label><caption><p>The 18 mismatch repair-associated genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Order</th><th align="center" valign="bottom" rowspan="1" colspan="1">Name</th><th align="center" valign="bottom" rowspan="1" colspan="1">Gene name</th><th align="center" valign="bottom" rowspan="1" colspan="1">Entrez gene</th><th align="center" valign="bottom" rowspan="1" colspan="1">mRMR score</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">HNRNPL</td><td align="left" valign="top" rowspan="1" colspan="1">Heterogeneous nuclear ribonucleoprotein L</td><td align="right" valign="top" rowspan="1" colspan="1">3191</td><td align="center" valign="top" rowspan="1" colspan="1">0.285</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">HPSE</td><td align="left" valign="top" rowspan="1" colspan="1">Heparanase</td><td align="right" valign="top" rowspan="1" colspan="1">10855</td><td align="center" valign="top" rowspan="1" colspan="1">0.097</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">CAB39L</td><td align="left" valign="top" rowspan="1" colspan="1">Calcium binding protein 39 like</td><td align="right" valign="top" rowspan="1" colspan="1">81617</td><td align="center" valign="top" rowspan="1" colspan="1">0.081</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">MTA2</td><td align="left" valign="top" rowspan="1" colspan="1">Metastasis associated 1 family member 2</td><td align="right" valign="top" rowspan="1" colspan="1">9219</td><td align="center" valign="top" rowspan="1" colspan="1">0.093</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">RAPGEF6</td><td align="left" valign="top" rowspan="1" colspan="1">Rap guanine nucleotide exchange factor 6</td><td align="right" valign="top" rowspan="1" colspan="1">51735</td><td align="center" valign="top" rowspan="1" colspan="1">0.086</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">LYG1</td><td align="left" valign="top" rowspan="1" colspan="1">Lysozyme g1</td><td align="right" valign="top" rowspan="1" colspan="1">129530</td><td align="center" valign="top" rowspan="1" colspan="1">0.081</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">SEC22B</td><td align="left" valign="top" rowspan="1" colspan="1">SEC22 homolog B, vesicle trafficking protein (gene/pseudogene)</td><td align="right" valign="top" rowspan="1" colspan="1">9554</td><td align="center" valign="top" rowspan="1" colspan="1">0.081</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">BRD3</td><td align="left" valign="top" rowspan="1" colspan="1">Bromodomain containing 3</td><td align="right" valign="top" rowspan="1" colspan="1">8019</td><td align="center" valign="top" rowspan="1" colspan="1">0.076</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">H2AFJ</td><td align="left" valign="top" rowspan="1" colspan="1">H2A histone family member J</td><td align="right" valign="top" rowspan="1" colspan="1">55766</td><td align="center" valign="top" rowspan="1" colspan="1">0.079</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">RAB12</td><td align="left" valign="top" rowspan="1" colspan="1">RAB12, member RAS oncogene family</td><td align="right" valign="top" rowspan="1" colspan="1">201475</td><td align="center" valign="top" rowspan="1" colspan="1">0.072</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">TGFBR2</td><td align="left" valign="top" rowspan="1" colspan="1">Transforming growth factor &#x003b2; receptor 2</td><td align="right" valign="top" rowspan="1" colspan="1">7048</td><td align="center" valign="top" rowspan="1" colspan="1">0.078</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">STRN3</td><td align="left" valign="top" rowspan="1" colspan="1">Striatin 3</td><td align="right" valign="top" rowspan="1" colspan="1">29966</td><td align="center" valign="top" rowspan="1" colspan="1">0.076</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">INO80D</td><td align="left" valign="top" rowspan="1" colspan="1">INO80 complex subunit D</td><td align="right" valign="top" rowspan="1" colspan="1">54891</td><td align="center" valign="top" rowspan="1" colspan="1">0.076</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">MLH1</td><td align="left" valign="top" rowspan="1" colspan="1">MutL homolog 1</td><td align="right" valign="top" rowspan="1" colspan="1">4292</td><td align="center" valign="top" rowspan="1" colspan="1">0.079</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">EIF5A</td><td align="left" valign="top" rowspan="1" colspan="1">Eukaryotic translation initiation factor 5A</td><td align="right" valign="top" rowspan="1" colspan="1">1984</td><td align="center" valign="top" rowspan="1" colspan="1">0.072</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">MIR3916</td><td align="left" valign="top" rowspan="1" colspan="1">microRNA 3916</td><td align="right" valign="top" rowspan="1" colspan="1">100500849</td><td align="center" valign="top" rowspan="1" colspan="1">0.069</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">FOXO3</td><td align="left" valign="top" rowspan="1" colspan="1">Forkhead box O3</td><td align="right" valign="top" rowspan="1" colspan="1">2309</td><td align="center" valign="top" rowspan="1" colspan="1">0.069</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">FBXO21</td><td align="left" valign="top" rowspan="1" colspan="1">F-box protein 21</td><td align="right" valign="top" rowspan="1" colspan="1">23014</td><td align="center" valign="top" rowspan="1" colspan="1">0.069</td></tr></tbody></table></table-wrap><table-wrap id="tIV-ol-0-0-8860" orientation="portrait" position="float"><label>Table IV.</label><caption><p>Common downstream genes of chromosome instability, CpG island methylator phenotype and mismatch repair.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="bottom" colspan="8" rowspan="1">List of common genes</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">A1BG</td><td align="left" valign="top" rowspan="1" colspan="1">CD248</td><td align="left" valign="top" rowspan="1" colspan="1">DEFB131</td><td align="left" valign="top" rowspan="1" colspan="1">HECA</td><td align="left" valign="top" rowspan="1" colspan="1">LCE1A</td><td align="left" valign="top" rowspan="1" colspan="1">NAIP</td><td align="left" valign="top" rowspan="1" colspan="1">SEMA4C</td><td align="left" valign="top" rowspan="1" colspan="1">TRMU</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A1CF</td><td align="left" valign="top" rowspan="1" colspan="1">CDKAL1</td><td align="left" valign="top" rowspan="1" colspan="1">DEFB134</td><td align="left" valign="top" rowspan="1" colspan="1">HES2</td><td align="left" valign="top" rowspan="1" colspan="1">LCE1B</td><td align="left" valign="top" rowspan="1" colspan="1">NCDN</td><td align="left" valign="top" rowspan="1" colspan="1">SERINC3</td><td align="left" valign="top" rowspan="1" colspan="1">TSEN15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABCC5</td><td align="left" valign="top" rowspan="1" colspan="1">CEP120</td><td align="left" valign="top" rowspan="1" colspan="1">DEFB135</td><td align="left" valign="top" rowspan="1" colspan="1">HES3</td><td align="left" valign="top" rowspan="1" colspan="1">LCE1D</td><td align="left" valign="top" rowspan="1" colspan="1">NCR3</td><td align="left" valign="top" rowspan="1" colspan="1">SERINC5</td><td align="left" valign="top" rowspan="1" colspan="1">TSEN2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABHD12</td><td align="left" valign="top" rowspan="1" colspan="1">CFAP58</td><td align="left" valign="top" rowspan="1" colspan="1">DNAJC9</td><td align="left" valign="top" rowspan="1" colspan="1">HGFAC</td><td align="left" valign="top" rowspan="1" colspan="1">LCE1E</td><td align="left" valign="top" rowspan="1" colspan="1">NCR3LG1</td><td align="left" valign="top" rowspan="1" colspan="1">SETDB2</td><td align="left" valign="top" rowspan="1" colspan="1">TSEN34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABHD6</td><td align="left" valign="top" rowspan="1" colspan="1">CGREF1</td><td align="left" valign="top" rowspan="1" colspan="1">DYSF</td><td align="left" valign="top" rowspan="1" colspan="1">HHLA2</td><td align="left" valign="top" rowspan="1" colspan="1">LCE3B</td><td align="left" valign="top" rowspan="1" colspan="1">NSUN4</td><td align="left" valign="top" rowspan="1" colspan="1">SLC16A7</td><td align="left" valign="top" rowspan="1" colspan="1">TSEN54</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABI3</td><td align="left" valign="top" rowspan="1" colspan="1">CGRRF1</td><td align="left" valign="top" rowspan="1" colspan="1">EMB</td><td align="left" valign="top" rowspan="1" colspan="1">HHLA3</td><td align="left" valign="top" rowspan="1" colspan="1">LCE3C</td><td align="left" valign="top" rowspan="1" colspan="1">NTNG1</td><td align="left" valign="top" rowspan="1" colspan="1">SLC30A8</td><td align="left" valign="top" rowspan="1" colspan="1">UBAP2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABI3BP</td><td align="left" valign="top" rowspan="1" colspan="1">CLASRP</td><td align="left" valign="top" rowspan="1" colspan="1">ENAM</td><td align="left" valign="top" rowspan="1" colspan="1">HLA-DOA</td><td align="left" valign="top" rowspan="1" colspan="1">LCN1</td><td align="left" valign="top" rowspan="1" colspan="1">NTNG2</td><td align="left" valign="top" rowspan="1" colspan="1">SLC36A2</td><td align="left" valign="top" rowspan="1" colspan="1">UNKL</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACOT13</td><td align="left" valign="top" rowspan="1" colspan="1">CLEC2A</td><td align="left" valign="top" rowspan="1" colspan="1">ETV7</td><td align="left" valign="top" rowspan="1" colspan="1">HLA-DOB</td><td align="left" valign="top" rowspan="1" colspan="1">LETM1</td><td align="left" valign="top" rowspan="1" colspan="1">OR10H1</td><td align="left" valign="top" rowspan="1" colspan="1">SLC3A1</td><td align="left" valign="top" rowspan="1" colspan="1">UPK1A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ADAT1</td><td align="left" valign="top" rowspan="1" colspan="1">CLK2</td><td align="left" valign="top" rowspan="1" colspan="1">FAM149B1</td><td align="left" valign="top" rowspan="1" colspan="1">HMGN3</td><td align="left" valign="top" rowspan="1" colspan="1">LIAS</td><td align="left" valign="top" rowspan="1" colspan="1">ORAOV1</td><td align="left" valign="top" rowspan="1" colspan="1">SLC51A</td><td align="left" valign="top" rowspan="1" colspan="1">UPK1B</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ADAT2</td><td align="left" valign="top" rowspan="1" colspan="1">CLK3</td><td align="left" valign="top" rowspan="1" colspan="1">FAM3C</td><td align="left" valign="top" rowspan="1" colspan="1">HOXC13</td><td align="left" valign="top" rowspan="1" colspan="1">LIPT2</td><td align="left" valign="top" rowspan="1" colspan="1">PANK1</td><td align="left" valign="top" rowspan="1" colspan="1">SLC51B</td><td align="left" valign="top" rowspan="1" colspan="1">UPK2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ADAT3</td><td align="left" valign="top" rowspan="1" colspan="1">CLK4</td><td align="left" valign="top" rowspan="1" colspan="1">FAT4</td><td align="left" valign="top" rowspan="1" colspan="1">HPCA</td><td align="left" valign="top" rowspan="1" colspan="1">LMBR1L</td><td align="left" valign="top" rowspan="1" colspan="1">PANK2</td><td align="left" valign="top" rowspan="1" colspan="1">SLC6A18</td><td align="left" valign="top" rowspan="1" colspan="1">UPK3A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AGR2</td><td align="left" valign="top" rowspan="1" colspan="1">CLN6</td><td align="left" valign="top" rowspan="1" colspan="1">FBXO38</td><td align="left" valign="top" rowspan="1" colspan="1">IGLL1</td><td align="left" valign="top" rowspan="1" colspan="1">LRRC4</td><td align="left" valign="top" rowspan="1" colspan="1">PANK3</td><td align="left" valign="top" rowspan="1" colspan="1">SLC6A19</td><td align="left" valign="top" rowspan="1" colspan="1">UPK3B</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AGR3</td><td align="left" valign="top" rowspan="1" colspan="1">CLN8</td><td align="left" valign="top" rowspan="1" colspan="1">FJX1</td><td align="left" valign="top" rowspan="1" colspan="1">IGSF3</td><td align="left" valign="top" rowspan="1" colspan="1">LRRC4C</td><td align="left" valign="top" rowspan="1" colspan="1">PANK4</td><td align="left" valign="top" rowspan="1" colspan="1">SLC6A20</td><td align="left" valign="top" rowspan="1" colspan="1">VEZT</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AMBN</td><td align="left" valign="top" rowspan="1" colspan="1">CNBD1</td><td align="left" valign="top" rowspan="1" colspan="1">FLCN</td><td align="left" valign="top" rowspan="1" colspan="1">IGSF6</td><td align="left" valign="top" rowspan="1" colspan="1">LXN</td><td align="left" valign="top" rowspan="1" colspan="1">PCTP</td><td align="left" valign="top" rowspan="1" colspan="1">SLC6A9</td><td align="left" valign="top" rowspan="1" colspan="1">VN1R1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AMICA1</td><td align="left" valign="top" rowspan="1" colspan="1">COASY</td><td align="left" valign="top" rowspan="1" colspan="1">FNIP2</td><td align="left" valign="top" rowspan="1" colspan="1">IGSF9B</td><td align="left" valign="top" rowspan="1" colspan="1">LYPD3</td><td align="left" valign="top" rowspan="1" colspan="1">PHF11</td><td align="left" valign="top" rowspan="1" colspan="1">SLC7A9</td><td align="left" valign="top" rowspan="1" colspan="1">VNN2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ANO5</td><td align="left" valign="top" rowspan="1" colspan="1">COMMD10</td><td align="left" valign="top" rowspan="1" colspan="1">FOXQ1</td><td align="left" valign="top" rowspan="1" colspan="1">IKBIP</td><td align="left" valign="top" rowspan="1" colspan="1">MARCO</td><td align="left" valign="top" rowspan="1" colspan="1">PIP</td><td align="left" valign="top" rowspan="1" colspan="1">SMDT1</td><td align="left" valign="top" rowspan="1" colspan="1">VPREB1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APOBEC1</td><td align="left" valign="top" rowspan="1" colspan="1">COMMD7</td><td align="left" valign="top" rowspan="1" colspan="1">FUZ</td><td align="left" valign="top" rowspan="1" colspan="1">INTU</td><td align="left" valign="top" rowspan="1" colspan="1">MCU</td><td align="left" valign="top" rowspan="1" colspan="1">PLXDC1</td><td align="left" valign="top" rowspan="1" colspan="1">SP8</td><td align="left" valign="top" rowspan="1" colspan="1">XAGE1B</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AZGP1</td><td align="left" valign="top" rowspan="1" colspan="1">COMMD8</td><td align="left" valign="top" rowspan="1" colspan="1">GABRR1</td><td align="left" valign="top" rowspan="1" colspan="1">KBTBD6</td><td align="left" valign="top" rowspan="1" colspan="1">MDGA1</td><td align="left" valign="top" rowspan="1" colspan="1">PPCDC</td><td align="left" valign="top" rowspan="1" colspan="1">SPICE1</td><td align="left" valign="top" rowspan="1" colspan="1">XAGE2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BCS1L</td><td align="left" valign="top" rowspan="1" colspan="1">CPA1</td><td align="left" valign="top" rowspan="1" colspan="1">GABRR2</td><td align="left" valign="top" rowspan="1" colspan="1">KBTBD7</td><td align="left" valign="top" rowspan="1" colspan="1">METTL9</td><td align="left" valign="top" rowspan="1" colspan="1">PPCS</td><td align="left" valign="top" rowspan="1" colspan="1">SPINK9</td><td align="left" valign="top" rowspan="1" colspan="1">YAE1D1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BFSP1</td><td align="left" valign="top" rowspan="1" colspan="1">CPA4</td><td align="left" valign="top" rowspan="1" colspan="1">GNPTAB</td><td align="left" valign="top" rowspan="1" colspan="1">KCNK10</td><td align="left" valign="top" rowspan="1" colspan="1">MFSD10</td><td align="left" valign="top" rowspan="1" colspan="1">PRLH</td><td align="left" valign="top" rowspan="1" colspan="1">SPINT1</td><td align="left" valign="top" rowspan="1" colspan="1">YIPF3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BFSP2</td><td align="left" valign="top" rowspan="1" colspan="1">CPN1</td><td align="left" valign="top" rowspan="1" colspan="1">GNPTG</td><td align="left" valign="top" rowspan="1" colspan="1">KCNK2</td><td align="left" valign="top" rowspan="1" colspan="1">MICU1</td><td align="left" valign="top" rowspan="1" colspan="1">PRLHR</td><td align="left" valign="top" rowspan="1" colspan="1">ST14</td><td align="left" valign="top" rowspan="1" colspan="1">YIPF4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BSCL2</td><td align="left" valign="top" rowspan="1" colspan="1">CPN2</td><td align="left" valign="top" rowspan="1" colspan="1">GP2</td><td align="left" valign="top" rowspan="1" colspan="1">KCNK4</td><td align="left" valign="top" rowspan="1" colspan="1">MICU2</td><td align="left" valign="top" rowspan="1" colspan="1">PRSS8</td><td align="left" valign="top" rowspan="1" colspan="1">STYX</td><td align="left" valign="top" rowspan="1" colspan="1">YRDC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CARHSP1</td><td align="left" valign="top" rowspan="1" colspan="1">CRISP3</td><td align="left" valign="top" rowspan="1" colspan="1">GRID2</td><td align="left" valign="top" rowspan="1" colspan="1">KIAA0319</td><td align="left" valign="top" rowspan="1" colspan="1">MMS22L</td><td align="left" valign="top" rowspan="1" colspan="1">PTCD3</td><td align="left" valign="top" rowspan="1" colspan="1">SUGP2</td><td align="left" valign="top" rowspan="1" colspan="1">ZCCHC17</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCDC109B</td><td align="left" valign="top" rowspan="1" colspan="1">CRYBA1</td><td align="left" valign="top" rowspan="1" colspan="1">GRID2IP</td><td align="left" valign="top" rowspan="1" colspan="1">KLF7</td><td align="left" valign="top" rowspan="1" colspan="1">MSRA</td><td align="left" valign="top" rowspan="1" colspan="1">RASD2</td><td align="left" valign="top" rowspan="1" colspan="1">TM2D1</td><td align="left" valign="top" rowspan="1" colspan="1">ZFR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCDC179</td><td align="left" valign="top" rowspan="1" colspan="1">CRYBB1</td><td align="left" valign="top" rowspan="1" colspan="1">GRXCR1</td><td align="left" valign="top" rowspan="1" colspan="1">KLK5</td><td align="left" valign="top" rowspan="1" colspan="1">MSRB2</td><td align="left" valign="top" rowspan="1" colspan="1">RBBP9</td><td align="left" valign="top" rowspan="1" colspan="1">TM2D2</td><td align="left" valign="top" rowspan="1" colspan="1">ZNF461</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCDC68</td><td align="left" valign="top" rowspan="1" colspan="1">CTAGE5</td><td align="left" valign="top" rowspan="1" colspan="1">GSX2</td><td align="left" valign="top" rowspan="1" colspan="1">KLRF2</td><td align="left" valign="top" rowspan="1" colspan="1">MSRB3</td><td align="left" valign="top" rowspan="1" colspan="1">RPUSD4</td><td align="left" valign="top" rowspan="1" colspan="1">TMEM126B</td><td align="left" valign="top" rowspan="1" colspan="1">ZNF772</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCIN</td><td align="left" valign="top" rowspan="1" colspan="1">CXADR</td><td align="left" valign="top" rowspan="1" colspan="1">GTPBP1</td><td align="left" valign="top" rowspan="1" colspan="1">KRTAP24-1</td><td align="left" valign="top" rowspan="1" colspan="1">MTERF4</td><td align="left" valign="top" rowspan="1" colspan="1">RSRP1</td><td align="left" valign="top" rowspan="1" colspan="1">TMEM19</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD101</td><td align="left" valign="top" rowspan="1" colspan="1">CYLC1</td><td align="left" valign="top" rowspan="1" colspan="1">GTPBP3</td><td align="left" valign="top" rowspan="1" colspan="1">KRTAP25-1</td><td align="left" valign="top" rowspan="1" colspan="1">MTO1</td><td align="left" valign="top" rowspan="1" colspan="1">SCGB2A2</td><td align="left" valign="top" rowspan="1" colspan="1">TMEM27</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD200</td><td align="left" valign="top" rowspan="1" colspan="1">DCDC2</td><td align="left" valign="top" rowspan="1" colspan="1">HAS1</td><td align="left" valign="top" rowspan="1" colspan="1">KRTAP27-1</td><td align="left" valign="top" rowspan="1" colspan="1">MUCL1</td><td align="left" valign="top" rowspan="1" colspan="1">SCGB3A2</td><td align="left" valign="top" rowspan="1" colspan="1">TONSL</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD200R1</td><td align="left" valign="top" rowspan="1" colspan="1">DEFB110</td><td align="left" valign="top" rowspan="1" colspan="1">HAS3</td><td align="left" valign="top" rowspan="1" colspan="1">L3MBTL1</td><td align="left" valign="top" rowspan="1" colspan="1">MYO7A</td><td align="left" valign="top" rowspan="1" colspan="1">SDCBP2</td><td align="left" valign="top" rowspan="1" colspan="1">TOX2</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><table-wrap id="tV-ol-0-0-8860" orientation="portrait" position="float"><label>Table V.</label><caption><p>Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichments of common downstream genes of chromosome instability, CpG island methylator phenotype and mismatch repair.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Type</th><th align="center" valign="bottom" rowspan="1" colspan="1">Gene set</th><th align="center" valign="bottom" rowspan="1" colspan="1">FDR</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">KEGG</td><td align="left" valign="top" rowspan="1" colspan="1">hsa00770 Pantothenate and CoA biosynthesis</td><td align="center" valign="top" rowspan="1" colspan="1">4.35E-11</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">hsa00785 Lipoic acid metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">0.0226</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">hsa04514 Cell adhesion molecules (CAMs)</td><td align="center" valign="top" rowspan="1" colspan="1">0.0476</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GO BP</td><td align="left" valign="top" rowspan="1" colspan="1">GO:0015937 coenzyme A biosynthetic process</td><td align="center" valign="top" rowspan="1" colspan="1">9.66E-08</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0015936 coenzyme A metabolic process</td><td align="center" valign="top" rowspan="1" colspan="1">1.32E-06</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0033866 nucleoside bisphosphate biosynthetic process</td><td align="center" valign="top" rowspan="1" colspan="1">1.72E-06</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0034030 ribonucleoside bisphosphate biosynthetic process</td><td align="center" valign="top" rowspan="1" colspan="1">1.72E-06</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0034033 purine nucleoside bisphosphate biosynthetic process</td><td align="center" valign="top" rowspan="1" colspan="1">1.72E-06</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0008033 tRNA processing</td><td align="center" valign="top" rowspan="1" colspan="1">6.32E-05</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0009451 RNA modification</td><td align="center" valign="top" rowspan="1" colspan="1">0.000240</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0033865 nucleoside bisphosphate metabolic process</td><td align="center" valign="top" rowspan="1" colspan="1">0.000267</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0033875 ribonucleoside bisphosphate metabolic process</td><td align="center" valign="top" rowspan="1" colspan="1">0.000267</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0034032 purine nucleoside bisphosphate metabolic process</td><td align="center" valign="top" rowspan="1" colspan="1">0.000267</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0015804 neutral amino acid transport</td><td align="center" valign="top" rowspan="1" colspan="1">0.000561</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0006865 amino acid transport</td><td align="center" valign="top" rowspan="1" colspan="1">0.00215</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0015807 L-amino acid transport</td><td align="center" valign="top" rowspan="1" colspan="1">0.00215</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0046942 carboxylic acid transport</td><td align="center" valign="top" rowspan="1" colspan="1">0.00218</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0000379 tRNA-type intron splice site recognition and cleavage</td><td align="center" valign="top" rowspan="1" colspan="1">0.00218</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0006399 tRNA metabolic process</td><td align="center" valign="top" rowspan="1" colspan="1">0.00233</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0015849 organic acid transport</td><td align="center" valign="top" rowspan="1" colspan="1">0.00254</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0036444 mitochondrial calcium uptake</td><td align="center" valign="top" rowspan="1" colspan="1">0.00277</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0015711 organic anion transport</td><td align="center" valign="top" rowspan="1" colspan="1">0.00408</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0008544 epidermis development</td><td align="center" valign="top" rowspan="1" colspan="1">0.00408</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0031424 keratinization</td><td align="center" valign="top" rowspan="1" colspan="1">0.00458</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0030855 epithelial cell differentiation</td><td align="center" valign="top" rowspan="1" colspan="1">0.00458</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0006820 anion transport</td><td align="center" valign="top" rowspan="1" colspan="1">0.00458</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:1905039 carboxylic acid transmembrane transport</td><td align="center" valign="top" rowspan="1" colspan="1">0.00473</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GO MF</td><td align="left" valign="top" rowspan="1" colspan="1">GO:0000213 tRNA-intron endonuclease activity</td><td align="center" valign="top" rowspan="1" colspan="1">5.22E-05</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0004594 pantothenate kinase activity</td><td align="center" valign="top" rowspan="1" colspan="1">5.22E-05</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0015171 amino acid transmembrane transporter activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.000748</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0008514 organic anion transmembrane transporter activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.000748</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0046943 carboxylic acid transmembrane transporter activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.000760</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0008509 anion transmembrane transporter activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.00112</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0005342 organic acid transmembrane transporter activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.00112</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0015175 neutral amino acid transmembrane transporter activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.00162</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0016892 endoribonuclease activity, producing 3&#x02032;-phosphomonoesters</td><td align="center" valign="top" rowspan="1" colspan="1">0.00230</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0004549 tRNA-specific ribonuclease activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.0128</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0015179 L-amino acid transmembrane transporter activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.0221</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0005328 neurotransmitter:sodium symporter activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.0291</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0005212 structural constituent of eye lens</td><td align="center" valign="top" rowspan="1" colspan="1">0.0333</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0016894 endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3&#x02032;-phosphomonoesters</td><td align="center" valign="top" rowspan="1" colspan="1">0.0458</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0008251 tRNA-specific adenosine deaminase activity</td><td align="center" valign="top" rowspan="1" colspan="1">0.0462</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GO CC</td><td align="left" valign="top" rowspan="1" colspan="1">GO:1990246 uniplex complex</td><td align="center" valign="top" rowspan="1" colspan="1">0.000199</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0000214 tRNA-intron endonuclease complex</td><td align="center" valign="top" rowspan="1" colspan="1">0.00661</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0005886 plasma membrane</td><td align="center" valign="top" rowspan="1" colspan="1">0.0114</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0071944 cell periphery</td><td align="center" valign="top" rowspan="1" colspan="1">0.0114</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0031526 brush border membrane</td><td align="center" valign="top" rowspan="1" colspan="1">0.0125</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0098590 plasma membrane region</td><td align="center" valign="top" rowspan="1" colspan="1">0.0125</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0098862 cluster of actin-based cell projections</td><td align="center" valign="top" rowspan="1" colspan="1">0.0148</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0044459 plasma membrane part</td><td align="center" valign="top" rowspan="1" colspan="1">0.0168</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">GO:0001533 cornified envelope</td><td align="center" valign="top" rowspan="1" colspan="1">0.0242</td></tr></tbody></table></table-wrap></floats-group></article>